Your session is about to expire
← Back to Search
CGM and Lifestyle Changes for Prediabetes
N/A
Recruiting
Led By Larry A Fox, MD
Research Sponsored by Nemours Children's Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients are pubertal, defined as females with breast Tanner stage II or above, or males with testicular volume ≥4 mL
Overweight or obese (BMI ≥85th percentile for age/sex)
Must not have
Taking medications that affect insulin sensitivity (e.g., metformin, chronic corticosteroids whether systemic or inhaled)
Existing diagnosis of type 1 or type 2 diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 and 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial studies how a continuous glucose monitor (CGM) can help obese children lower their risk of type 2 diabetes (T2D) & other complications like hypertension & dyslipidemias. It's hypothesized that real-time glucose data will help improve adherence to lifestyle modifications, leading to better BMI & insulin sensitivity.
Who is the study for?
This trial is for overweight or obese children aged 10 to less than 17 with impaired glucose tolerance but not diagnosed with diabetes. They must be in puberty and willing to wear a continuous glucose monitor (CGM). Those on medications affecting insulin sensitivity or unwilling to comply are excluded.
What is being tested?
The study tests if using a CGM device helps these young patients stick better to lifestyle changes, potentially leading to weight loss and improved insulin sensitivity, reducing the risk of developing type 2 diabetes and other obesity-related complications.
What are the potential side effects?
While the use of CGM itself isn't associated with significant side effects, there may be minor skin irritation where the device attaches. The lifestyle changes could include increased physical activity and dietary adjustments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have started puberty.
Select...
My BMI is in the top 15% for my age and sex.
Select...
I am between 10 and 16 years old.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am on medication that affects my body's response to insulin, like metformin.
Select...
I have been diagnosed with type 1 or type 2 diabetes.
Select...
I am unwilling or unable to wear a CGM device for the study period.
Select...
I have not yet gone through puberty.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 and 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Insulin Sensitivity Score (ISS)
Secondary study objectives
Dietary compliance questionnaires
Glycemic levels
Insulin Sensitivity Score
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: CGM interventionExperimental Treatment1 Intervention
Continuous glucose monitoring with real-time glucose data using Dexcom G6.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CGM
2013
N/A
~1030
Find a Location
Who is running the clinical trial?
Nemours Children's ClinicLead Sponsor
127 Previous Clinical Trials
18,408 Total Patients Enrolled
Larry A Fox, MDPrincipal InvestigatorNemours Children's Health
4 Previous Clinical Trials
44 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have trouble processing sugar, as shown by a specific test.I am on medication that affects my body's response to insulin, like metformin.I have been diagnosed with type 1 or type 2 diabetes.I have started puberty.I am unwilling or unable to wear a CGM device for the study period.I have not yet gone through puberty.My BMI is in the top 15% for my age and sex.I am between 10 and 16 years old.
Research Study Groups:
This trial has the following groups:- Group 1: CGM intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger